Brief: Resonance Health Says Hepafatsmart Cleared By US FDA
29/06/2023 02:24
June 29 (Reuters) - Resonance Health Ltd RHT.AX :
* UPDATED HEPAFATSMART CLEARED BY US FDA
* RECEIVED REGULATORY CLEARANCE FROM US FDA TO MARKET
HEPAFATSMART
Source text for Eikon: ID:nASXb97HcC
Further company coverage: RHT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsAustralia's Resonance Health jumps on FY26 forecast hike
Brief: Resonance Health Expects FY26 Underlying EBITDA A$2.6 Mln
Brief: Resonance Health Says Martin Blake Retires As Chair
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln
Brief: Resonance Seeks Trading Halt Pending Announcement On Execution Of Contract For Services For Clinical Trial By Pharma Co